115 related articles for article (PubMed ID: 24270196)
1. Triage of women with negative cytology and positive high-risk HPV: an analysis of data from the SHENCCAST II/III studies.
Goodrich SK; Pretorius RG; Du H; Wu R; Belinson JL
J Low Genit Tract Dis; 2014 Apr; 18(2):122-7. PubMed ID: 24270196
[TBL] [Abstract][Full Text] [Related]
2. [Performance of vaginal self-sampling high-risk HPV genotyping as primary and combining cytology or viral load as secondary in cervical cancer screening].
Guo CL; Luo HX; Wang C; Qu XF; Yang B; Belinson JL; Du H; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2021 Apr; 56(4):271-279. PubMed ID: 33902239
[No Abstract] [Full Text] [Related]
3. High-risk human papillomavirus detection in women with low-grade squamous intraepithelial lesions or higher-grade cytology using the Cervista HPV HR test.
Gold MA; Thomas MA; Huh WK; Sarto GE; Day SP
J Low Genit Tract Dis; 2013 Jan; 17(1):51-7. PubMed ID: 22885641
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of The Cervista HPV A9 group In Screening Patients for Cervical Cancer.
Zhao J; Du H; Belinson JL; Qu X; Zhang W; Mei J; Yang B; Wang C; Zhang L; Wu R
J Med Screen; 2016 Mar; 23(1):38-43. PubMed ID: 26466824
[TBL] [Abstract][Full Text] [Related]
5. Clinical validation of the Cervista HPV HR and 16/18 genotyping tests for use in women with ASC-US cytology.
Einstein MH; Martens MG; Garcia FA; Ferris DG; Mitchell AL; Day SP; Olson MC
Gynecol Oncol; 2010 Aug; 118(2):116-22. PubMed ID: 20488510
[TBL] [Abstract][Full Text] [Related]
6. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
[TBL] [Abstract][Full Text] [Related]
7. Management of HPV-positive women in cervical screening using results from two consecutive screening rounds.
Polman NJ; Veldhuijzen NJ; Heideman DAM; Snijders PJF; Meijer CJLM; Berkhof J
Int J Cancer; 2019 May; 144(9):2339-2346. PubMed ID: 30565673
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of high-risk HPV DNA genotyping for primary cervical cancer screening and triage of HPV-positive women, compared to cytology: preliminary results of the PIPAVIR study.
Chatzistamatiou K; Moysiadis T; Angelis E; Kaufmann A; Skenderi A; Jansen-Duerr P; Lekka I; Kilintzis V; Angelidou S; Katsiki E; Hagemann I; Tsertanidou A; Koch I; Boecher O; Soutschek E; Maglaveras N; Agorastos T
Arch Gynecol Obstet; 2017 May; 295(5):1247-1257. PubMed ID: 28337594
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
[TBL] [Abstract][Full Text] [Related]
10. A new PCR-based mass spectrometry system for high-risk HPV, part II: clinical trial.
Du H; Yi J; Wu R; Belinson SE; Qu X; Yang B; Wang C; Yi X; Belinson JL
Am J Clin Pathol; 2011 Dec; 136(6):920-3. PubMed ID: 22095378
[TBL] [Abstract][Full Text] [Related]
11. Improved sensitivity of vaginal self-collection and high-risk human papillomavirus testing.
Belinson JL; Du H; Yang B; Wu R; Belinson SE; Qu X; Pretorius RG; Yi X; Castle PE
Int J Cancer; 2012 Apr; 130(8):1855-60. PubMed ID: 21630255
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of careHPV, Cervista Human Papillomavirus, and Hybrid Capture 2 Methods in Diagnosing Cervical Intraepithelial Neoplasia Grade 2+ in Xinjiang Uyghur Women.
Tuerxun G; Yukesaier A; Lu L; Aierken K; Mijiti P; Jiang Y; Abulizi A; Zhang Y; Abuduxikuer G; Abulizi G; Li H
Oncologist; 2016 Jul; 21(7):825-31. PubMed ID: 27317575
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus testing in young women: clinical outcomes of human papillomavirus triage in a UK cervical screening program.
McKenna M; McMenamin MM
Cancer Cytopathol; 2014 Sep; 122(9):702-10. PubMed ID: 24888573
[TBL] [Abstract][Full Text] [Related]
14. Clinical performance characteristics of the Cervista HPV HR test kit in cervical cancer screening in China.
Zhao J; Zhang X; Ma J; Liu G; Yao D; Zhang W; Wang J; Wei L; Zhao Y; Zeng Y; Liao Q
J Low Genit Tract Dis; 2012 Oct; 16(4):358-63. PubMed ID: 23023138
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of alternately combining HPV viral load and 16/18 genotyping in secondary screening algorithms.
Luo H; Du H; Belinson JL; Wu R
PLoS One; 2019; 14(7):e0220200. PubMed ID: 31348794
[TBL] [Abstract][Full Text] [Related]
16. The ideal strategy for cervical cancer screening in Japan: Result from the Fukui Cervical Cancer Screening Study.
Kurokawa T; Onuma T; Shinagawa A; Chino Y; Kobayashi M; Yoshida Y
Cytopathology; 2018 Aug; 29(4):361-367. PubMed ID: 29768678
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Viral Load as a Triage Strategy With Primary High-Risk Human Papillomavirus Cervical Cancer Screening.
Luo H; Belinson JL; Du H; Liu Z; Zhang L; Wang C; Qu X; Pretorius RG; Wu R
J Low Genit Tract Dis; 2017 Jan; 21(1):12-16. PubMed ID: 27851695
[TBL] [Abstract][Full Text] [Related]
18. Management of high-risk HPV-positive women for detection of cervical (pre)cancer.
Luttmer R; De Strooper LM; Steenbergen RD; Berkhof J; Snijders PJ; Heideman DA; Meijer CJ
Expert Rev Mol Diagn; 2016 Sep; 16(9):961-74. PubMed ID: 27459506
[TBL] [Abstract][Full Text] [Related]
19. Prevention of cervical cancer in women with ASCUS in the Brazilian Unified National Health System: cost-effectiveness of the molecular biology method for HPV detection.
Nomelini RS; Guimarães PD; Candido PA; Campos AC; Michelin MA; Murta EF
Cad Saude Publica; 2012 Nov; 28(11):2043-52. PubMed ID: 23147946
[TBL] [Abstract][Full Text] [Related]
20. Immediate biopsy of cervical cytology-negative and non-HPV-16/18 oncogenic types positive patients.
Karaca İ; Öztürk M; Comba C; Demirayak G; Alay İ; Erdoğan VŞ; Hoşgören M; Yaşar L
Diagn Cytopathol; 2018 Apr; 46(4):326-330. PubMed ID: 29460502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
